MedTrace Logo

Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes

NCT01456026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2011-10-20

No results posted yet for this study

Summary

Recent evidence supports detrimental effects of advanced glycation endproducts (AGE) on vascular function (VF). Though, the effect of AGE-modified proteins alone on vascular function remained unknown. Therefore, the aim of our study is to investigate the effects of heat-treated, glycated beta-lactoglobulins (BLG) on vascular function in subjects with type 2 diabetes mellitus (T2DM) and to compare it to non-glycated, heat-treated BLG.

Conditions

Interventions

DIETARY_SUPPLEMENT

Glycated beta-lactoglobulins.

oral, 20 g, single administration

DIETARY_SUPPLEMENT

Non-glycated beta-lactoglobulins

20 g, oral, single administration,

Sponsors & Collaborators

Principal Investigators

  • Alin O Stirban, M.D. · Profil Institute for Metabolic Research GmbH

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01456026 on ClinicalTrials.gov